entity

SLC16A1 (MCT1)

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SLC16A1 (MCT1): its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
2Hypotheses
1Analyses
1Outgoing
0Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
metabolomicsimplicates_indisease0.45

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Restoration of Neuronal Ketone Body Utilization via MCT1 Upr 0.450 metabolomics Metabolomic signatures of neurodegenerat
Novel Hypothesis on Metabolic Dysregulation in Neurodegenera 0.330 - -

Mentioning Analyses (1)

Scientific analyses that reference this entity

Metabolomic signatures of neurodegeneration: metabolic reprogramming in aging br

metabolomics | 2026-04-16 | 7 hypotheses Top: 0.520

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

What are the key metabolic alterations detectable in brain tissue, CSF, and bloo

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Related Research

Hypotheses and analyses mentioning SLC16A1 (MCT1) in their description or question text

No additional research found